Researchers identified a link between migraine characteristics and diets rich in certain nutrients.
Results of a cross-sectional study identified relationships between dietary nutrient patterns and intensity and duration of migraine headache among female migraineurs. Findings were published in British Journal of Nutrition and suggest dietary nutrient patterns should be monitored closely in individuals suffering from migraine, the authors wrote.
A disorder of the endogenous pain modulating system, sensitivity to hemostasis alteration, and vascular changes have all been explored as potential roots of migraine pathology. However, “although migraine may originate from hereditary causes, various other internal and external conditions, such as daily diet, certain foods, alcohol, hormonal fluctuations, stressful situations, and lifestyle may affect the intensity and duration of migraine,” the researchers explained.
Previous research has also largely focused on the role of individual foods in migraine, while less attention has been paid to the impact of dietary patterns. To address this knowledge gap, investigators assessed the relationship between dietary nutrient patterns and duration of migraines among 266 women in Iran.
“Nutrient patterns can provide a prospective view between total food intake and disease, where consideration is given to the impact of all dietary nutrients,” the authors wrote. “In addition, studying dietary and nutrient patterns can also encompass both the food synergy and nutrients' interactions.”
All study participants were aged 18 to 50 years and had body mass indices between 18.5 and 30.0 kg/m2. The International Physical Activity Questionnaire was used to assess physical activity, and dietary intake was assessed via the food frequency questionnaire. In addition, Nutritionist-IV software was used to analyze data, while dietary macronutrients, vitamins, and minerals were computed from total intake.
To assess migraine intensity, the researchers employed the Migraine Disability Assessment (MIDAS) questionnaire and Visual Analog Scale (VAS). Fifteen nutrients were selected for factor analysis and used to extract 3 dietary patterns. Specifically, “the first nutrient pattern consisted of calcium, vitamin A, vitamin K, vitamin C, vitamin B6, vitamin B2, and magnesium. The second nutrient pattern included vitamin B1, carbohydrate, vitamin B3, vitamin B9, protein, and total fiber. The third tertile included vitamin D and vitamin B12.”
Analyses revealed:
The current study confirms the importance of identifying triggers for the management of migraine and underscores how the consumption or avoidance of specific dietary nutrient patterns could impact disease severity, researchers said.
However, the cross-sectional design of the analysis precludes any causal inferences from being drawn, marking a limitation to the study. Future prospective longitudinal studies are warranted to better elucidate the association between dietary nutrient patterns and migraine characteristics, they concluded.
Reference
Bahrampour N, Mirzababaei A, Yarizadeh H, et al. The relationship between dietary nutrients patterns and intensity and duration of migraine headaches. Br J Nutr. Published online January 17, 2022. doi:10.1017/S0007114522000046
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
CGRP Inhibitors: A Promising New Class of Drugs for Migraine
November 14th 2018This fall, The American Journal of Managed Care® convened a panel of experts on migraine to discuss calcitonin gene-related peptide (CGRP) inhibitors, an emerging therapy for the condition, which affects 39 million people in the United States.
Listen